메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

Hypershell Publishes First Consumer Exoskeleton Standards White Paper, Calling for Industry-Wide Transparency and Unified Testing Frameworks

[ 메디채널 황정호 기자 ] SGS-verified performance results underscore the need for reproducible, third-party testing across the emerging wearable robotics sector SHENZHEN, China, Dec. 8, 2025 -- Hypershell, the originator of the outdoor consumer exoskeleton category, today released the industry's first Consumer Exoskeleton Standards White Paper, establishing a foundational framework for transparent, reproducible, and scientifically rigorous evaluation of wearable mobility devices. The white paper includes newly published, independently conducted and Société Générale
- 황정호 기자
- 2025-12-08 21:00
PT Fapon and PT Bio Farma Forge Strategic Partnership to Advance IVD Localization and Innovation in Indonesia

DONGGUAN, China, Dec. 8, 2025 -- PT Fapon Bioindustries Indonesia (referred to as "PT Fapon") and the Indonesian state-owned pharmaceutical holding company PT Bio Farma (Persero) (referred to as "Bio Farma") officially signed a cooperation agreement at Fapon's headquarters in Dongguan. The partnership is centered on the local manufacturing, and commercialization of IVD products in Indonesia. Mrs. Dyah, Chief Executive Officer of Fapon Indonesia Market, and Mr. Dicky, Head of the Business Development Division at Bio Farma, formally executed the agreement on behalf of their respe
- 김갑성 기자
- 2025-12-08 20:47
Servier's Voranigo® (vorasidenib) Receives Prix Galien Awards Across Multiple Regions

Voranigo® has been awarded the Prix Galien USA, the Prix Galien Poland and the Prix Galien Bridges Awards for Best Product for Orphan/Rare Diseases. These awards across several geographies recognize the progress represented by Voranigo® for patients living with glioma. SURESNES, France, Dec. 8, 2025 -- Servier, an independent international pharmaceutical group governed by a foundation, today announced that Voranigo® (vorasidenib) has been awarded the inaugural 2025 Prix Galien Bridges Award for Best Product for Orphan/Rare Diseases, during a ceremony held in
- 김갑성 기자
- 2025-12-08 20:24
Aurora Names Seasoned Global CPG Executive to Lead Australia and New Zealand

NASDAQ | TSX: ACB EDMONTON, AB, Dec. 8, 2025 -- Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, announces Kerry Miller, a 35-year consumer packaged goods executive, as Managing Director for Australia and New Zealand, effective January 15, 2026. Kerry will be instrumental in driving growth in these key markets, drawing on decades of global experience in fast moving, regulated industries. "I'm excited to join Aurora at an inflection point in the company's global leadership and to work alongside a team dedicate
- 김갑성 기자
- 2025-12-08 20:00
Huya Announces January 7, 2026 Open Beta Launch for Goose Goose Duck Mobile in Chinese Mainland

GUANGZHOU, China, Dec. 8, 2025 -- HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA), a leading game-related entertainment and services provider, today announced that the popular social deduction game Goose Goose Duck mobile, co‑published by Huya and Kingsoft Shiyou in the Chinese mainland, is scheduled to enter open beta on January 7, 2026. The launch represents a significant step in Huya's strategic expansion into game publishing, broadening its role in the gaming value chain. The title has attracted more than 10 million pre‑registrations as of November 2025, bolste
- 김장윤(JASON KIM) 기자
- 2025-12-08 19:30
Global Stars Confirmed as the Games of the Future Abu Dhabi 2025 Finalises Full Line-Up

Some of the biggest names in phygital sports and esports from around the world will head to Abu Dhabi for the ultimate showdown in next-gen sports from 18-23 December. DUBAI, UAE, Dec. 8, 2025 -- Phygital International, the UAE-headquartered promoter of phygital sports worldwide, today confirms the full competitive line-up for the Games of the Future Abu Dhabi 2025 (GOTF 2025), the world's leading international phygital tournament. The announcement finalises the elite roster of competitors confirmed to take part, with a stellar line up including world champions, top-ranked espo
- 황정호 기자
- 2025-12-08 18:54
Goodix Powers Samsung's Galaxy Z TriFold with Advanced Foldable Touch and Fingerprint Solutions

SHENZHEN, China, Dec. 8, 2025 -- Goodix Technology today announced that its industry‑leading main & sub touchscreen controller and ultra‑narrow side‑key capacitive fingerprint solution are featured in Samsung's first multi-folding phone, Galaxy Z TriFold. Leveraging Goodix's advanced technologies, the revolutionary device delivers an immersive and interactive large‑screen experience and seamless, convenient biometric unlocking. To meet the demanding requirements of multi-folding form factor, Goodix developed a customized touch solution optimized for the Galaxy Z TriFold. Th
- 김장윤(JASON KIM) 기자
- 2025-12-08 18:20
Pepperstone Expands UAE Presence with SCA Category 5 Licence and New Dubai Office

DUBAI, UAE, Dec. 8, 2025 -- Pepperstone, a leading global online broker, has expanded its footprint in the UAE with the granting of a Category 5 licence by the UAE Securities and Commodities Authority (SCA) and the opening of a new onshore office in Dubai at Emaar Square, Building 3, 3rd Floor, Office 2. This development marks a significant evolution of Pepperstone's regional strategy, positioning the firm even closer to key stakeholders in one of the world's most sophisticated and fast-growing trading ecosystems. The SCA Category 5 licence authorises Pepperstone to conduct &qu
- 황정호 기자
- 2025-12-08 18:04
Ascletis' Oral Small Molecule GLP-1, ASC30, Demonstrated Placebo-Adjusted Weight Loss of 7.7% with Better Gastrointestinal Tolerability in Its 13-Week U.S. Phase II Study in Participants with Obesity or Overweight

- ASC30 once-daily tablets showed statistically significant and clinically meaningful dose-dependent placebo-adjusted mean body weight reductions with no observed plateau for weight loss. - ASC30 titrated weekly to target dose demonstrated approximately one-half the rate of vomiting observed with orforglipron titrated weekly. - No hepatic safety signal was observed, and no elevations of alanine transaminase (ALT), aspartate aminotransferase (AST) or total bilirubin (TBL) were observed. - Two conference calls/webcasts are scheduled to discuss the results, including a
- 김갑성 기자
- 2025-12-08 17:40
DAR GLOBAL AND ART DISTRICT REAL ESTATE DEVELOPMENT ANNOUNCE 'MAD', MUSCAT'S MARINE, ART & DIGITAL DISTRICT

MUSCAT, Oman, Dec. 8, 2025 -- Dar Global (LSE: DAR), the London-listed luxury real estate developer, in partnership with Art District Real Estate Development, today announced the start of the collaboration to launch and develop 'MAD', Muscat Marine, Art & Digital District, a transformative new coastal destination that integrates oceanfront living, luxury hospitality, culture-led enterprise, and future-focused finance and digital industries. Located along Oman's picturesque coastline, the 'MAD' project spans over 1.5 million square meters with a gross development value of ap
- 황정호 기자
- 2025-12-08 17:14

이전

91 92 93 94 95 96 97 98 99 100

많이 본 기사

최근기사

2026-01-12_MON

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 01월 12일 15시 00분